QT Imaging CEO Letter Reveals H1 Revenue Up 116%, $39M FY Guidance, and New CPT Code

summarizeSummary

QT Imaging's mid-year shareholder letter discloses H1 revenue of $14.0 million (up 116% YoY), reaffirms $39 million FY guidance, and announces a new CPT code effective January 2027 — a reimbursement milestone that could accelerate U.S. adoption.

check_boxKey Events · Earnings and Guidance · QTI

• H1 Revenue Up 116%

  H1 2026 revenue reached $14.0 million, up 116% year-over-year, with 28 Breast Acoustic CT scanners shipped — double the prior-year period.

• FY2026 Guidance Reaffirmed at $39M

  Management reiterated full-year 2026 revenue guidance of approximately $39 million, implying continued strong scaling from $18.9 million in 2025.

• New CPT Code Effective Jan 2027

  The AMA approved a Category III CPT code for 3D quantitative transmission volumetric ultrasound tomography of the breast, effective January 1, 2027 — a key step toward U.S. reimbursement.

• Cash Position of $14.2M

  As of August 7, 2026, the company held approximately $14.2 million in cash and restricted cash, providing runway for commercial and clinical priorities.

auto_awesomeAnalysis · QTI · Industrial Applications And Services

The shareholder letter provides materially new information beyond last week's Q2 release: H1 revenue of $14.0 million (up 116% YoY), full-year guidance of approximately $39 million, a cash position of $14.2 million, and a Category III CPT code effective January 1, 2027. The CPT code is a key reimbursement milestone that could accelerate U.S. adoption, while the revenue trajectory and cash balance address near-term liquidity concerns raised by the prior quarter's $8.3 million debt charge.